Evaluation of Nicorandil in Treatment of induced pulmonary arterial hypertension in male Rats
Pulmonary arterial hypertension (PAH) is a chronic, rare, and non-treatable disease, resulting in elevated mean arterial pressure (≥25mmHg) during rest and (≥30mmHg) during exercise. Pulmonary arteries remodeling including endothelial apoptosis, smooth muscle hyperplasia, and endothelial dysfunct...
Saved in:
Main Authors: | Taha Hashim Ahmed (Author), Israa Burhan Raoof (Author), Bahir Abdul-Razzaq Mshemish (Author) |
---|---|
Format: | Book |
Published: |
College of Pharmacy / Mustansiriyah University,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Testicular Protection Effect of Thiamine Pyrophosphate Against Cisplatin-treated Male Rats
by: Maitham Abd Ali Mnati, et al.
Published: (2022) -
In vitro effect of nicorandil on the carbachol-induced contraction of the lower esophageal sphincter of the rat
by: Tomonori Shimbo, et al.
Published: (2016) -
Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
by: Yi Tong, et al.
Published: (2018) -
Paclitaxel-Induced Endothelial Dysfunction in Living Rats Is Prevented by Nicorandil via Reduction of Oxidative Stress
by: Ken-ichi Serizawa, et al.
Published: (2012) -
Role of Secretory Phospholipase A2 in Rhythmic Contraction of Pulmonary Arteries of Rats With Monocrotaline-Induced Pulmonary Arterial Hypertension
by: Yoshiyuki Tanabe, et al.
Published: (2012)